School of Medicine
Showing 51-100 of 106 Results
-
Huijun Ring
Adjunct Professor, Primary Care and Population Health
Temp - Non-Exempt, Sustainability AcceleratorBioDr. Huijun Ring received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics.
Dr. Ring is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She was the founder and CEO of iDNA Inc, a precision medicine company. iDNA Inc. was named as one of the fastest growing technology companies in China by Deloitte and was acquired by a public company. She has also cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs.
Currently, Dr Ring is an Adjunct Professor at Department of Medicine, and Senior Director of Market Engagement at Stanford Sustainability Accelerator. She works on developing bio-solutions for Sustainability, including synthetic biology, biomanufacturing and sustainable food. At Stanford Sustainability Accelerator, we accelerate the translation of Stanford research into impactful policy and technology solutions to address global sustainability challenges. She is involved in mentoring Stanford Graduate School of Business students, Knight-Hennessy Scholars, and junior women faculty in science and medicine through the Stanford University Faculty Development Office. Dr. Ring also teaches the course “Science and History of Traditional Chinese Medicine” and serves as a faculty advisor for the Stanford iGEM (International Genetically Engineered Machine) team. -
Sonia Rios-Ventura
Family Health Navigator, Medicine - Med/Oncology
BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.
She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing. -
Norman Rizk
Berthold and Belle N. Guggenhime Professor, Emeritus
Current Research and Scholarly InterestsI am interested in the prevention and control of critical care-related illnesses and complications, including ventilator-associated pneumonia, spread of nosocomial infections, and prognosis of multiple organ system failure in intensive care units. Infections and complications of therapy in immunocompromised hosts, including effects of chemotherapy and hematopoetic stem cell transplants is another interest.
-
Jennifer Robinson
Associate Director, Medicine - Med/Stanford Prevention Research Center
Current Role at StanfordAssociate Director, Nutrition Studies Group
-
Thomas Robinson
The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.
-
William H. Robinson, MD PhD
James W. Raitt, M.D. Professor
Current Research and Scholarly InterestsOur lab investigates the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and osteoarthritis.
The overriding objectives of our laboratory are:
1. To elucidate the mechanisms underlying autoimmune and rheumatic diseases.
2. To investigate the role of innate immune inflammation in osteoarthritis.
3. To develop novel diagnostics and therapeutics -
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Dulce Rodriguez
Temporary Employee, Primary Care and Population Health
BioAs a researcher in the field of Technology & Health, my research interest lies in the design and implementation of technology-framed health care solutions to improve human life and well-being. I have conducted research projects with a diverse range of populations, including older adults, children, adolescents, and underrepresented communities. My multi-disciplinary academic and professional background enables me to approach technology from a human-centered perspective, ensuring that the solutions I design are tailored to meet the unique needs of the individuals and communities I work with.
-
Fatima Rodriguez
Associate Professor of Medicine (Cardiovascular Medicine)
BioFatima Rodriguez, MD, MPH is an Associate Professor in Cardiovascular Medicine and (by courtesy) the Stanford Prevention Research Center. Dr. Rodriguez earned her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health. She then completed internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford University. She currently serves as the Section Chief of Preventive Cardiology. Dr. Rodriguez specializes in cardiovascular disease prevention, inherited lipid disorders, and cardiovascular risk assessment in high-risk populations.
Dr. Rodriguez’s research includes a range of topics around racial, ethnic, and gender disparities in cardiovascular disease prevention, developing novel interventions to address disparities, and opportunistic screening of coronary artery disease. -
Stephan Rogalla, M.D. PhD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsThe research interest of myself and my lab are in the field of early cancer detection using targeted molecular spies to highlight (pre)cancerous lesions. We as well aim to improve precision medicine in autoimmune disorders like inflammatory bowel disease and oncology.
-
Albert "A.J." Rogers, MD, MBA
Instructor, Medicine - Cardiovascular Medicine
BioDr. Albert “A.J.” Rogers, MD, MBA is a clinical cardiac electrophysiologist and cardiovascular research scientist at Stanford University. He is trained in cardiac electrophysiology, biomedical and software engineering, signal processing, and data science. Clinically, his expertise is in complex arrhythmia mapping and ablation, including atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. He also performs cardiac device implantation of leadless pacemakers, conduction system pacing, cardiac resynchronization therapy, defibrillators, and event recorders. In research, he is supported by the National Institutes of Health (NIH) and other agencies to investigate pathophysiology, diagnosis, and treatment of heart rhythm disorders. His research explores the mechanisms of cardiac arrhythmia using signal processing, machine learning, and in silico modeling. He has over 10 years of medical technology innovation and development experience ranging from design to preclinical and clinical studies.
-
Angela Rogers
Associate Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Nidhi Rohatgi, MD MS
Clinical Professor, Medicine
Clinical Professor (By courtesy), NeurosurgeryBioNidhi Rohatgi, MD, MS, SFHM is a Clinical Professor of Medicine and Section Chief for Surgical Co-management (Neurosurgery, Orthopedic surgery, and ENT) in the Division of Hospital Medicine at Stanford University School of Medicine. She primarily manages medical co-morbidities and strives to prevent medical complications in post-surgical patients in the hospital setting. She has led several quality improvement and clinical research studies and is passionate about finding innovative, cost-efficient and sustainable solutions in healthcare. She serves as an investigator in NIH and industry sponsored clinical trials and is the Director of Clinical Research (Palo Alto) in the Division of Hospital Medicine and an Affiliated Faculty at the Center for Artificial Intelligence in Medicine and Imaging at Stanford University. She is an invited speaker at national and international meetings and serves on several national committees. She is the recipient of local, national, and international awards for her work as a clinician, educator, and researcher. She is a strong advocate for patient experience and serves as the Medical Director for the Clinical Advice Services at Stanford Health Care.
-
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Dana Nirel Romalis
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDana Romalis has been a board certified Family Medicine physician since 2004. She enjoys taking care of families throughout all phases of life. Special interests include teaching, collaborative care, preventative medicine, behavioral change, and reproductive and adolescent health. Since 2017, she has been a primary care provider at the Life Connections Health Center in San Jose, caring for Cisco employees and their families.
She was born and raised in Vancouver, Canada, where she also attended medical school at the University of British Columbia. As an undergraduate at Brandeis University, she double majored in Neuroscience and Psychology, and was captain of the women’s varsity diving team. She did her residency at Montefiore Medical Center’s Residency Program of Social Medicine in the Bronx, NY.
Prior to joining Stanford’s primary care division in 2017, she worked for 10 years as a physician at Santa Clara Valley Medical Center on their interdisciplinary Valley Homeless Healthcare Program. She is committed to comprehensive and compassionate care for all.
In her spare time, she enjoys spending time with her husband and 2 teenagers, reading, hiking, biking, and volunteering in her community. -
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine and Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Lisa Goldman Rosas
Assistant Professor (Research) of Epidemiology and Population Health and of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics
BioLisa Goldman Rosas, PhD MPH is an Assistant Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in chronic diseases such as diabetes, heart disease, depression, and cancer among racial/ethnic minority families. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing diversity in biomedical research.
-
Glenn Rosen
Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus
Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.
-
Larissa Roux MD PhD
Adjunct Professor, Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Corey Rovzar
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
Current Research and Scholarly InterestsEnhancing human movement through scalable, remotely delivered physical activity interventions, remote assessment and monitoring of human movement, health technology development, fall prevention, aging, digital balance assessment, improving access to health and healthcare, increasing healthspan, lifestyle medicine
-
Mohana Roy, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Roy is a medical oncologist and a clinical assistant professor in the Stanford University School of Medicine Department of Medicine, Division of Medical Oncology. She has expertise in Lung and Thoracic cancers, but with a broad clinical interest in hematology and oncology.
Dr. Roy became an oncologist because of her passion for patient care. She is committed to being a clinician and is focused on improving the patient experience -- from the moment a patient checks in, to how information about their care is conveyed, and how the complex process of getting cancer care can be made a bit more seamless.
Her research interests include access to clinical trials, quality improvement and improving care delivery. In that effort, she has published on work regarding patient reported outcomes (PROs) and their use to help clinical quality efforts- including in the context of a clinical trial with an electronic PRO portal, through distress screening with the Stanford Medicine Cancer Center, and in improving access to such screening and care for patient with limited English proficiency. She is the recipient of both a clinical innovation award through Stanford and an American Society of Clinical Oncology (ASCO) Merit award.
She is the Associate Medical Director for Quality at Stanford Cancer Center from 2022.
Dr. Roy received her medical degree from Albert Einstein College of Medicine, and then completed residency training at Beth Israel Deaconess Medical Center. She then completed fellowship training in Hematology and Oncology at Stanford. She was chief fellow for her graduating year during fellowship as well. -
Michael Royer
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
Current Research and Scholarly InterestsDr. Royer's research interests include food insecurity, eating behaviors, and physical activity. His research primarily aims to remove barriers hindering individuals from accessing healthy food. Dr. Royer seeks to advance public health by sustainably promoting healthy eating and food security through innovative and evidence-based research approaches. Through his research, he is motivated to promote food security, healthy eating, and physical activity toward the prevention of chronic disease.
-
Daniel Rubin
Professor of Biomedical Data Science, of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology
Current Research and Scholarly InterestsMy research interest is imaging informatics--ways computers can work with images to leverage their rich information content and to help physicians use images to guide personalized care. Work in our lab thus lies at the intersection of biomedical informatics and imaging science.
-
Michael Rubin
Adjunct Professor, Medicine
BioMichael P. Rubin, MD, PhD is the Founder and CEO of Northpond Ventures, a multi-billion dollar science driven venture capital firm. Northpond is based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Dr. Rubin has been involved in investing in and developing over 100 startups, in a broad array of disciplines, including medicine, technology, financial services, and global consumer. Dr. Rubin’s experience spans engineering, medicine, surgery, venture capital, and entrepreneurship. Dr. Rubin also holds academic appointments at Harvard and MIT.